Who we are

Why BioGenomics

01–03 / 05
BioGenomics award icon

Quality that matches only the best

BioGenomics establishes biosimilarity by a thorough characterisation process, using modern technologies which are compliant with global regulatory requirements.

All our product are animal-origin free.

BioGenomics gear icon

cGMP Production Facility

WHO-GMP certified. Advanced formulation capabilities. ISO 9001:2015, ISO 14001 and ISO 45001 certified.

BioGenomics brain icon

Strong IP portfolio for Value Creation

BioGenomics’ innovations cover super vectors for mammalian and microbial expressions, codon optimised gene sequences, protein folding technologies, novel purification and isolation technologies.

BioGenomics dna icon

Indigenous to the core

Completely indigenous technology at each stage of development, including cell lines and process development.

All manufacturing processes established for robustness, using modern ‘Quality by Design’ concepts.

BioGenomics globe icon

International standard clinical safety and efficacy trials

Clinical studies designed with reference to EMA guidelines and conducted to ICH-GCP.

Statistically significant and meaningful clinical trials.

Clinical trials aimed at establishing biosimilarity, immunogenicity and efficacy using globally sourced reference products.

Global presence

Partnering with leaders to expand responsible access